BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
PBX1
,
T cell differentiation
,
Breast Cancer
,
Lymphocyte
,
Amniocentesis
,
Prozac
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
antigens cd38
Summary
General Info
Curated Studies
Most Correlated Studies
Tonsil centroblast cells CD19+ CD38hi CD10+ IgD- CXCR4+ stimulated with CD40L and IL21
Hematopoietic stem cells from umbilical cord blood sorted for CD34+ CD38- CD45RA- CD90+ CD49f+
CD8+ naive or activated T cells from PBMCs of dengue or dengue hemorrhagic patients
Bone marrow plasma cell subsets
Blood cell subpopulations from acute myeloid leukemia (AML) patients
Explore Curated Studies Results
Literature
Most Relevant Literature
CD38 Expression by Antigen-Specific CD4 T Cells Is Significantly Restored 5 Months After Treatment I…
Pre-clinical evaluation of CD38 chimeric antigen receptor engineered T cells for the treatment of mu…
A novel modified vaccination technique produces IgG antibodies that cause complement-mediated lysis …
Tandem Native Mass-Spectrometry on Antibody-Drug Conjugates and Submillion Da Antibody-Antigen Prote…
Multiple myeloma yields to CD38 inhibitors.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Study to Assess Allogeneic Anti-CD38 A2 Dimeric Antigen Receptor T Cells in Relapsed or Refractory M…
Integrin β7, BCMA, CS1, CD38 and CD138 as the Single or Compound Targets for the Fourth Genenation o…
CID-103 (Anti-CD38 Antibody) in Previously Treated Relapsed or Refractory Multiple Myeloma
A Phase I/IIa Study of Human Anti-CD38 Antibody MOR03087 (MOR202) in Relapsed/Refractory Multiple My…
Higher Percentage of CD34+ CD38- Cells Detected by Multiparameter Flow Cytometry From Leukapheresis …
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ